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Abstract.  Both the cellular and scrapie isoforms of 
the prion protein (PrP) designated PrP  c and PrP  s" are 
encoded by a  single-copy chromosomal gene and ap- 
pear to be translated from the same 2.1-kb mRNA. 
PrP  c can be distinguished from PrP  s~ by limited pro- 
teolysis under conditions where PrP  c  is hydrolyzed 
and PrP  s~ is resistant. We report here that PrP  c can be 
released from the surface of both normal-control and 
scrapie-infected murine neuroblastoma (N2a) cells by 
phosphatidylinositol-specific phospholipase C  (PIPLC) 
digestion and it can be selectively labeled with sulfo- 
NHS-biotin, a  membrane impermeant reagent. In con- 
trast, PrP  s~ was neither released by PIPLC nor labeled 
with sulfo-NHS-biotin. Pulse-chase experiments 
showed that [35S]methionine was incorporated almost 
immediately into PrP  c while incorporation into PrP  s~ 
molecules was observed only during the chase period. 
While PrP  c is synthesized and degraded relatively rap- 
idly (h/2 •  5  h), PrP  s~ is synthesized slowly (tj/2 
,'~ 15 h) and appears to accumulate. These results are 
consistent with several observations previously made 
on rodent brains where PrP mRNA and PrP  c levels 
did not change throughout the course of scrapie infec- 
tion, yet PrP  s~ accumulated to levels exceeding that of 
PrP  c.  Our kinetic studies demonstrate that PrP  s~ is de- 
rived from a  protease-sensitive precursor and that the 
acquisition of proteinase K  resistance results from a 
posttranslational event.  Whether or not prolonged in- 
cubation periods, which are a cardinal feature of prion 
diseases,  reflect the slow synthesis of PrP  s~ remains to 
be established. 
VER the last five years, there has been a remarkable 
convergence of information about the prion protein 
(PrP) ~ (26,  39).  Biochemical studies  have  shown 
that scrapie prion infectivity and a protease-resistant core of 
scrapie prion protein (Prl  ~) designated PrP 27-30 copurify 
(27, 28). Furthermore, prolonged exposure of purified prion 
fractions  to  proteases  is  accompanied  by  a  concomitant 
degradation of  PrP 27-30 and a loss of scrapie infectivity (21). 
Solubilization of scrapie prions into detergent-lipid-protein 
complexes  (DLPCs)  (13) made  possible  immunoaItinity 
chromatography with PrP  monoclonal antibodies demon- 
strating the copurification of PrP  s~ and scrapie  infectivity 
(14). Neutralization of  scrapie infectivity  in DLPCs with PrP 
antiserum  has  also  been  observed.  Human and  hamster 
prions purified by limited proteolysis, detergent extraction, 
differential centrifugation and sucrose gradient sedimenta: 
tion  were  found to  aggregate  into  insoluble,  rod-shaped 
structures indistinguishable from many purified amyloids (6, 
28). This observation was extended to the brains of humans 
and animals dying of prion diseases where amyloid plaques 
were found to stain intensely with PrP antibodies (17, 32). 
1. Abbreviations used in this paper:  DLPC,  detergent-lipid-protein com- 
plex;  N2a,  routine  neuroblastoma;  PIPLC,  phosphatidylinositol-specific 
phospholipase  C; PrP,  prion protein;  PrP  c, cellular isoform of the prion 
protein;, PrP  sc,  scrapie  isoform  of the  priori  protein;  Sarkosyi,  sodium 
dodecyl sarcosinate;  ScN2a, scrapie-infected murine neuroblastoma. 
The foregoing studies argue persuasively that PrP  s~ is a 
major and necessary component of the infectious prion. Mo- 
lecular cloning studies established that PrP  s~ is encoded by a 
single-copy, chromosomal gene and not by a putative nucleic 
acid hiding within the prion (4, 10, 25). This is an important 
feature distinguishing prions from viruses. Although the PrP 
gene is highly regulated in the developing brain, it is consti- 
tutively expressed during the adult life of rodents (22, 24, 
25). The product of the PrP gene in normal animals and hu- 
mans is a protein designated PrP  c. Many lines of evidence 
suggest that PrP  c and PrP  s~ have the same amino acid se- 
quence but differ in their properties because of an as yet 
unidentified posttranslational event (3, 4). 
Until recently, cell culture systems have been disappoint- 
ing with respect to extending our knowledge of prions since 
prion titers are low and there is no recognizable cytopathic 
effect associated with scrapie infection. The identification of 
PrP  c on the surface of cultured cells (37) and PrP  s" in ex- 
tracts of these cells (8) suggested that scrapie-infected cells 
in culture might be used to study PrP  sc synthesis. We report 
here that PrP  c  can be  released  from the  surface of both 
normal-control and scrapie-infected murine neuroblastoma 
(N2a) cells by phosphatidylinositol-specific phospholipase 
C (PIPLC) digestion and it can be selectively labeled with 
sulfo-NHS-biotin, a membrane impermeant reagent. In con- 
trast, PrP  s~ was neither released by PIPLC nor labeled with 
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[35S]methionine was  incorporated almost immediately  into 
PrP  c while incorporation into PrP  s~ molecules was delayed 
for several hours. While PrP  c  is synthesized and degraded 
relatively  rapidly,  PrP  s~ is  synthesized slowly and appears 
to accumulate. The kinetic findings reported here demonstrate 
that  PrP  c  and  PrP  s~  have  different  rates  of  synthesis  and 
degradation and that these differences arise from posttransla- 
tional events. 
Materials and Methods 
Reagents 
PIPLC was a gift of Dr. Martin Low (Columbia University, NY). One unit 
of PIPLC will digest 1 /~mol of phosphatidylinositoi in 1 rain (19).  Pro- 
teinase K used in digestion of cellular extracts is a product of Beckman In- 
struments Inc. (Palo Alto, CA). Reagents for cell culture were obtained from 
the University of California San Francisco Cell Culture Facility except for 
Opti-MEM I which is a product of  Gibeo Laboratories (Grand Island, NY). 
Detergents for the extraction of cells and the solubilization of cellular pro- 
teins were obtained from Sigma Chemical Co.  (St.  Louis,  MO) as was 
PMSF and aprotinin. PAGE reagents were obtained from Bio-Rnd Laborato- 
ries (Richmond, CA). 
Cell Lines 
The uninfected N2a cell line used in this study was Obtained  from Ameri- 
can Type Tissue Culture Collection. A clonal cell line of scrapie-infected 
N2a cells (ScN2a)  was found to produce ,,o105 IDso U of prions/10  7 cells, 
and protease-resistant PrP  sc (8). The ScN2a subclone reported here was in 
continuous passage for '~18 mo and continued to produce PrP  sc at a con- 
slant level. Cell lines were maintained in DME with 10% FBS and penicil- 
lin/streptomycin in humidified incubators containing 5 % CO2.  In general, 
scrapie-infected  cultures were passaged every 7-10 d after a 1:5 or 1:10 split. 
Uninfected N2a cells were maintained in a  1:1  mixture of DME (+10% 
FBS) and Opti-MEM I (Gibco Laboratories) supplemented with penicillin 
and streptomycin, and passaged as required in 1:20 splits. 
PrP Antibodies 
All of the antisera used in this study to detect PrP  c  and PrP  sc molecules 
were prepared as previously described (2, 3, 5). Anti-PrP 27-30 rabbit sexa 
R017 and anti-PrP peptide PI rabbit antisera RDI3 have been described else- 
where and shown to react specifically with PrP  sc and PrP  c molecules pro- 
duced by ScN2a cells (2,  3,  8).  Anti-PrP 27-30 rabbit sera Rff73 was re- 
cently produced (35). This antisera recognizes PrP  sc or PrP  c molecules in 
extracts of N2a cells at a 1:5,000 dilution. R073 antiserum was used in Fig. 
1 while immune sera R013 or 17,017 was employed in Figs. 2-9. 
Extraction of CeUular Proteins for Immunoblot 
Analysis and Immunoprecipitation 
Radiolabeled and nomadioactive cellular proteins were extracted from cells 
in detergent essentially as previously described (8, 34). Before extraction, 
cultures were washed 2-3 times in PBS, then harvested with a disposable 
scraper and pelleted by centrifugation. Cell pellets were then resuspended 
in 0.05 M Tris-HCi, pH 7.5, 0.15 M NaCI, 0.005 M EDTA (TNE)and lysed 
on ice by adding Triton X-100 and deoxycholate to 0.5 %. Insoluble material 
was then removed by eentrifngation at 3,000 g before precipitation of  protein 
extracts with at least 4 vol of  methanol at -20°C for 30 min. After centrifu- 
gation at 5,000 g  for 20 rain, pellets were resuspended in TNE with 0.2% 
sodium dodecyl sarcosinate (Sarkosyl) and digested with 10-20 ttg/ml pro- 
teinase K for 30--60 min at 37°C, where applicable. Proteinase K digestions 
were terminated by addition of PMSF to 2-5 mM and methanol precipita- 
tion (4 vol). We have recently modified this procedure and found that more 
efficient  extraction was obtained when cells were treated directly on the cul- 
ture vessel in 1-2 ml of ice-cold THE, 0.5% Triton X-100, 0.5% deoxycho- 
late.  After removal of insoluble material by centrifugation, proteinase K 
digestion (10-20/tg/ml, 37°C, 60 min) can be carried out directly in the 
lysis buffer. All samples are then concentrated by methanol precipitation 
(4-10 vol) before immunoblot analysis or immunoaffim~ty purification. This 
modified procedure was used for the experiments depicted in Figs. 5, 6 and 
7. Each of these methods of extraction as well as proteinase K digestion 
yielded similar results. 
Proteins  released  into  the  medium by  PIPLC  were concentrated by 
precipitation with 4  vol of methanol before further analysis.  EDTA was 
added to a final concentration of 5 mM before methanol precipitation to re- 
duce the formation of insoluble CaPO4  precipitates. 
lmmunobiot Analysis 
After PAGE separation of  cellular proteins, PrP molecules were detected by 
electro-transfer  to nitrocellulose membrane in 0.02 M "Iris, 0.15 M glycine, 
20%  methanol, 0.02%  SDS at 500 mA overnight at 4°C. After transfer, 
membranes were washed briefly in H20, then washed for 1 h in PBS with 
5 % nonfat  dry milk (Carnation). After two additional washes in O.01 M Tris- 
HCI, pH 8.0, 0.15 M NaCI, 0.05%  Tween 20 (TBST) (10 rain each), mem- 
branes were further incubated in TBST with 10% horse serum for 45-60 
min. After removal of the TBST serum, membranes were incubated over- 
night in TBST with anti-PrP sera as described in the figure legends. Com- 
plexes between antibodies and prion proteins were then revealed using 
Promega anti-rabbit Ig antibodies coupled to alkaline phosphatase as de- 
scribed by Promega Biotec (Madison, WI). 
Immunoprecipitation 
Methanol-precipitated cellular proteins were resuspended in DLPC buffer 
consisting of 0.5-2  ml of 0.05  M  Tris-HCI pH  8.2,  0.15  M  NaCI,  2% 
(wt/voi) Sarkosyl,  0.4%  (wt/vol) phusphatidylcholine with  105  U/mi of 
aprotinin and sonicated for at least 3 rain. This procedure forms DLPCs that 
enhance the solubility  of PrP  sc and allows immunoaffinity  purification (14). 
Anti-PrP serum was added at a  1:250 or 1:500 dilution, and after over- 
night incubation at 4°C, protein-antibody complexes were adsorbed to pro- 
tein A-Sepharose (50 ~d/500 td of solubilized protein) for 30-60 min. Pro- 
tein A-adsorbed material was then washed in DLPC buffer for 30 min at 
4°C. This wash was followed by a second wash in 0.05 M Tris-HCl, pH 8.2, 
0.5 M NaCI, 1% Sarkosyl (TN-I% Sarkosyl). After 30 min, protein A-Seph- 
arose  was  transferred  to  a clean microfuge  tube  and  further  wasl~l  in  TN-I% 
Sarkosyl  3  times  for  5  rain  each.  Protein  A-Sepharose was  then  resuspended 
in  0.06275  M  Tris-HCl pH 6.8,  3% SDS, 25% sucrose,  I% ~-mercapto- 
ethanol,  0.015% hromophenol blue,  and  boiled  for  5 rain  before  PAGE and 
autoradiography  as described  (34). 
Metabolic Pulse-Chase  Radiolabeling  Experiments 
Cell cultures were starved in methionine-free  DME with 10% dialyzed FBS 
for 1 h prior to labeling. Labelings were generally for 2 h with 300/~Ci/ml 
[35S]methionine  in methionine-free DME containing 2.5% dialyzed FBS. 
Chase incubations were performed in regular cell cutlure medium (DME 
with 10% FBS) or in Opti-MEM I (Gibco Laboratories), a defined serum- 
free medium. Cells were harvested by extraction as described above. In 
some experiments chase medium (Opti-MEM I)  was also harvested by 
precipitation with 4  vol of methanol. 
Densitometry of  p'Sl-Met-Labeled  PrP 
Autoradingraphic signals were quantitated by densitometfic scanning using 
a model 620 instrument 0Bio-Rad  Laboratories). In each experiment, the 
relative amount of  PrP present  at any specific time during chase incubations 
is regarded as a percentage  of  the quantity of  nascent PrP recovered immedi- 
ately following the pulse-labeling period. The best fit to an exponential was 
calculated with a computer program that performs a nonlinear fit by min- 
imizing the sums of  the squares of  the residuals between  observed  and calcu- 
lated y-values. 
Results 
PIPLC Digestion Releases PrP  c but not PrP  s~ 
The PIPLC-catalyzed  release  of PrP  c  from the surface  of 
ScN2a cells is depicted in Fig.  1 A. Without PIPLC, little or 
no detectable PrP was found in the medium (lane/) and most 
of the PrP immunoreactivity remained cell associated (lane 
2).  Proteinase K  digestion of ScN2a cell  extracts  revealed 
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PrP  s~ remains cell associated.  This is an immunoblot that was de- 
veloped with PrP antiserum R073. (A) Confluent  10-cm dishes of 
ScN2a cells  were exposed to PIPLC (0.2 U/ml)  in PBS or PBS 
alone  at room temperature  for 3 h.  Cells  and medium  were ex- 
tracted or harvested, and digested with proteinase K as described 
in  Materials  and  Methods.  Lane  1  is  culture  medium  without 
PIPLC. Lanes 2 and 3 contain extracts of untreated cells incubated 
without  and  with proteinase  K,  respectively. Lanes 4  and 5  are 
PIPLC-released proteins incubated without and with proteinase K, 
respectively. Lanes 6 and 7are extracts of PIPLC-treated cells in- 
cubated without (lane 6) or with proteinase K (lane 7). Lane 8 con- 
tains  the PIPLC-released  PrP from one-half plate of ScN2a cells 
while lane 9 contains a mixture of the other half of the sample in 
lane 8 and an extract of one-half a plate of ScN2a cells. (B) Con- 
fluent cultures of ScN2a cells were exposed to PIPLC (0.2 U/ml) 
in  PBS. Cells  were  harvested,  extracted  in detergent,  and  pro- 
teinase  K  digested  before  comparative  immunoblot  analysis  of 
PIPLC-released  proteins and digested cell extracts. Lanes 1, 3, 5, 
and 7 contain serial 1:3 dilutions of proteins released from one 10- 
cm dish of ScN2a cells  by PIPLC.  Lanes 2,  4,  6, and 8 contain 
serial  1:3 dilutions of proteins found in proteinase K-digested ex- 
tracts of one 10-cm dish of ScN2a cells.  Lanes 9-12 are a control 
that shows that N2a ceils do not normally produce proteins which 
interfere  with  PrP  s~ immunoblot  transfer  and detection.  Lane  9, 
proteinase  K-digested ScN2a extract.  Lane  10,  proteinase  K-di- 
gested ScN2a extract mixed with an equivalent amount of protein- 
ase K-digested extract of uninfected N2a cells. Lanes 11 and 12 are 
serial  1:3 dilutions of sample electrophoresed  in lane 9. 
the characteristic pattern of PrP  s" (lane 3),  which is found 
in prion-infected N2a cells (8). PrP was found in the medi- 
um of ScN2a cells digested with PIPLC (lane 4);  however, 
this protein was degraded by proteinase K  (lane 5) demon- 
strafing that these molecules behave like PrP  c. The band seen 
in lane 5 is proteinase K, which reacts with some of our an- 
tisera raised against PrP 27-30 as previously described (5). 
In contrast,  PrP  s~ was not released by PIPLC (lanes 6 and 
7).  The immunostaining of PrP  c in cell extracts was prob- 
lematic but was greatly enhanced after partial purification by 
PIPLC digestion, which released it into the medium (corn- 
pare lanes 2  with 4).  The poor immunostaining of PrP  c in 
cell extracts probably results from competition with cellular 
proteins for binding to the transfer membrane since mixing 
of a  cell extract with PrP  c recovered after PIPLC (lane 8) 
greatly reduced the irnmunostaining intensity (lane 9). 
To assess the relative amounts of PrP  c and PrP  s~ in ScN:a 
cells, serial dilutions of the PrP  c released into the medium 
by PIPLC were compared to proteinase K-digested cell ex- 
tracts (Fig.  1 B, lanes 1-8). Since the immunostaining of the 
two samples exhibited a parallel decrease with the same dilu- 
tions, we conclude that ScN2a ceils contain roughly similar 
amounts of PrP  c and PrP  s~. This estimate must be tempered 
because we are uncertain  about the relative efficiencies of 
PrP  c and PrP  s~ transfer and binding to nitrocellulose as well 
as  their  immunoreactivity.  PrP  s"  immunostaining  was  di- 
minished by no more than a  factor of 2  if mixed with an 
equivalent  amount  of proteinase  K-digested  extract  from 
uninfected N~a cells (lanes 9--12). 
All of the ScN2a cells expressed PrP  c on their surface as 
assessed by indirect immunofluorescence (Fig. 2). The com- 
plete disappearance of immunostaining after PIPLC diges- 
tion of SeNna cells indicates that PrP  s~ cannot be visualized 
under  the  conditions  used  for these  studies.  Control  N2a 
cells before and after PIPLC digestion (in Fig. 2,  e and f) 
are indistinguishable from the ScN2a cells in PrP immuno- 
staining. 
PrP  sc in N2a Cells 
The ScN2a cell line used in this work is a  clonal cell line 
originally isolated by Butler and colleagues (8). Other inves- 
tigators have also reported long-term cultivation of ScN~a 
cells (9, 30, 31). We have maintained this clonal line in con- 
tinuous culture for over 18 mo. Occasionally cultures were 
found in which the  PrP  s" content was substantially dimin- 
ished.  However,  we observed no  decrease  in  the  level of 
PrP  s~ production in most instances.  25  subclones were ex- 
amined after ~6 mo of cultivation. All were found to pro- 
duce  PrP  s~  molecules.  10  additional  subclones  were  iso- 
lated after ~12 mo of continuous cultivation. Again, all were 
found  to  produce  PrP  s~ molecules  although  one  subclone 
produced significantly less than the parental population. 
During the course of this work, we have made several ob- 
servations  on  the  cultivation  of ScN2a  cells  that  warrant 
comment. We found that passage of the cultures every 7-10 
d split at a  1:5 or 1:10 ratio enhanced the reproducibility of 
experiments as well as the stability of the cell line. Cells that 
were stored in liquid nitrogen became,  unstable after thawing 
and  subcultivation,  and  produced  less  PrP  s~.  In  fact,  less 
than one-half of new subclones isolated from cells that had 
been  stored  in  liquid  nitrogen  for  6  mo  produced  PrP  s~ 
(data not shown). 
Topology of PrP  c Differs from PrP  s~ 
One explanation for the inability of PIPLC to release PrP  s~ 
from ScN2a cells could be that PrP  s~ is not transported to 
the  cell  surface.  To  investigate  the  topology  of PrP  s~  in 
ScN2a cells, we employed a membrane impermeant reagent 
(sulfo-NHS-biotin)  that  covalently  couples  biotin  to  free 
amino groups of cell surface proteins (16).  In control experi- 
ments,  crude  microsome preparations  of scrapie-infected 
mouse  brain  were  exposed  to  sulfo-NHS-biotin,  digested 
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PrP on the surface of normal and infected 
N2a cells.  Control  and  ScN2a cells  were 
plated onto glass microslide culture vessels. 
Cells were then incubated without (a, c, and 
e) or with (b, d, and f) PIPLC (0.2 U/ml) 
in PBS for 3 h at room temperature,  and 
then  incubated with  anti-PrP  serum R017 
and a fluorescein-conjugated goat anti-rab- 
bit Ig serum (diluted  1:100) (Boehringer- 
Mannheim,  Indianapolis,  IN). a and b are 
ScN2a ceils;  phase-contrast  and  immuno- 
fluorescent microscopy were used together 
to photograph the cells, c and d are an adja- 
cent field of cells visualized by immunoflu- 
orescence only. e and fare control N2a cells. 
Ceils stained with preimmune  serum R017 
give an immunofluorescence signal similar 
to that seen for PIPLC-treated cells exposed 
to immune serum (not shown). 
with proteinase K and analyzed by streptavidin shift PAGE/ 
immunoblot analysis (Borchelt, D., A. Taraboulos, M. Scott, 
D.  Bredesen,  N.  Stahl, and S. B.  Prusiner,  in preparation; 
N. Stahl, unpublished observations). PrP  sc proteins extracted 
from nonbiotinylated microsomes did not bind streptavidin 
and their PAGE migration was unaffected (Fig. 3 A, lanes 1 
and 2).  In contrast,  PrP  s~ molecules extracted from biotin- 
ylated microsomes exhibited a marked shift in PAGE migra- 
tion in the presence of streptavidin (Fig. 3 A, lanes 3 and 4). 
In addition,  large complexes of biotinylated PrP and strep- 
tavidin were found not to electrotransfer efficiently causing 
a  reduction in immunostaining.  These studies also showed 
that PrP  s" retained its protease resistance after reacting with 
sulfo-NHS-biotin. 
ScN2a  cells were exposed to  sulfo-NHS-biotin followed 
by PIPLC digestion. Cellular proteins were extracted and an 
aliquot  digested  with  proteinase  K.  PrP  c  released  from 
nonbiotinylated cultures did not bind streptavidin (Fig. 3 B, 
lanes  1  and 2).  In contrast,  the  PAGE migration  of PrP  c 
released from cells exposed to sulfo-NHS-biotin was retard- 
ed in the presence of streptavidin (Fig. 3 B, lane 4), but not 
by streptavidin preincubated with excess d-biotin (Fig. 3 B, 
lane 3). Since PrP  c released from biotinylated cultures quan- 
titatively bound streptavidin, the amount of sulfo-NHS-bio- 
tin used in these experiments (1 mg/ml) was clearly sufficient 
to  react  with  cell-surface  PrP.  PrP  s'  extracted  from bio- 
tinylated ScN2a cultures did not quantitatively bind strepta- 
vidin (200/~g) (Fig. 3 C, lane 4), while the PAGE migration 
of a  biotinylated control PrP  s~ added to the extract (Fig.  3 
C, lanes 1 and 2) was completely retarded. The migration of 
neither PrP  c nor PrP  s~ was affected by streptavidin (200/~g) 
preincubated with d-biotin (100 #g) (Fig. 3 C, lane 3). Simi- 
lar analysis of extracts of biotinylated ScN2a cells without 
the addition of control biotinylated PrP  c demonstrates that 
most PrP  s" was not accessible to sulfo-NHS-biotin (Fig.  3 
C, lanes 5  and 6).  The PAGE migration of PrP  s~ extracted 
from nonbiotinylated cultures appeared unaltered by strep- 
tavidin (Fig. 3 C, lane 7). The inaccessibility of most PrP  s" 
in ScN2a cells to sulfo-NHS-biotin suggests that the majority 
of PrP  s~ does not accumulate on the cell surface. 
Nascent PrP on the Surface of N2a Cells 
Uninfected N2a (Fig. 4 A) and ScN2a (Fig. 4 B) cells were 
incubated in medium with 300 tzCi/ml  pS]methionine for 
2 h before exposure to PIPLC (Fig. 4, lanes I and 2) or sulfo- 
NHS-biotin (Fig. 4,  lanes 3  and 4).  The radiolabeled pro- 
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examination  of the  ability  of mouse  PrP  s¢ to  react  with  sulfo- 
NHS-biotin and withstand proteinase  K digestion  was performed. 
Microsomal preparations (13) of scrapie-infected  mouse brain were 
exposed  to  1 mg/ml sulfo-NHS-biotin in H20 after brief sonica- 
tion.  After 20 min, Tris-HCl (pH 7.5) was added to make a final 
concentration of 0.1  M  before extraction  in detergent,  methanol 
precipitation,  and  digestion  with  proteinase  K  as  described  in 
Materials  and Methods.  Protein in each preparation was examined 
by streptavidin  shift  PAGE and  immunoblot analysis  with  poly- 
clonal  anti-PrP  27-30  serum  (R017). Biotinylated  proteins  bind 
streptavidin  resulting  in retarded migration on SDS-PAGE. Lanes 
1 and 2 are nonbiotinylated  microsomes without (lane  1) or with 
(lane 2) the addition  of 50/~g of streptavidin.  Lanes 3 and 4 are 
biotinylated  microsomes without (lane 3) and with (lane 4) the ad- 
dition of 50/~g of streptavidin.  (B and C) Confluent cultures  in 150 
cm  2 flasks (1 per lane)  were exposed to PBS containing 1 mg/ml 
sulfo-NHS-biotin, except where noted, for 20 min at room temper- 
ature.  After two washes with 0.1 M Tris-HCl pH 7.5, 0.1 M NaCI, 
and 2 washes with PBS, the cells were exposed to PIPLC (0.2 U/ml) 
in PBS for 2 h at room temperature.  The extent of PrP biotinylation 
in each fraction was then examined by streptavidin  shift PAGE and 
immunoblot analysis  for PrP proteins  as in A. (B) Lanes 1 and 2 
are PIPLC-released proteins from nonbiotinylated  cultures electro- 
phoresed in the presence of 20 ~tg of streptavidin  preincubated  with 
20/zg d-biotin (lane 1) or 20 #g of streptavidin  (lane 2).  Lanes 3 
and 4 are PIPLC-released proteins  from biotinylated  cultures  elec- 
trophoresed with streptavidin/biotin  or streptavidin  as in lanes  1 
and 2, respectively.  (C) Lanes I and 2 contain control biotinylated 
PrP  s¢ isolated  from scrapie-infected  hamster brain (38) and elec- 
trophoresed with 20 ttg of streptavidin  preincubated  with 20 #g of 
d-biotin or 20/zg of streptavidin  only (lane 2). Lanes 3 and 4 con- 
tain a  mixture of added biotinylated  hamster PrP  s¢ and proteins 
extracted  from  biotinylated  ScN2a  cultures  after  proteinase  K 
digestion  electrophoresed in the presence of 200/zg streptavidin 
preincubated  with  100 #g d-biotin (lane 3) or 200/~g streptavidin 
Figure 4.  Nascent PrP  c in control and scrapie-infected  N2a cells is 
transported to the cell  surface and partially released  by PIPLC. 
Confluent flasks  (25 cm  2) of normal and scrapie  N2a ceils  were 
metabolically  radiolabeled  for 2 h with 300 ttCi/ml  [35S]methio- 
nine in methionine-free  DME with 2.5% dialyzed FBS. One set of 
flasks was then exposed to 0.2 U/ml PIPLC in PBS for 3 h while 
a second set was exposed to sulfo-NHS-biotin in PBS for 20 min. 
Cells and medium were extracted in detergent or harvested,  and im- 
munoprecipitated  as described in Materials  and Methods.  (A) Nor- 
mal N2a cells.  (B) ScN2a cells.  Lanes 1 and 2 show released  and 
cell-associated  proteins  after  exposure  to  PIPLC,  respectively. 
Lanes 3 and 4 are proteins  immunoprecipitated  from biotinylated 
cultures electrophoresed in the presence of  50/zg streptavidin prein- 
cubated with 25 ttg d-biotin (lane 3) or 50/~g streptavidin  (lane 4). 
teins were then immunoprecipitated as DLPCs before analy- 
sis by SDS-PAGE. Similar amounts of PrP  c were observed 
in the medium (Fig.  4,  lane/),  and the cell pellet (lane 2) 
after exposure to either 0.2 or 2.0 U/ml PIPLC. In other ex- 
periments  using  immunofluorescence,  as  much as 90%  of 
the  PrP  c  seemed  to  be  released  from  the  surface  of N2a 
cells upon PIPLC digestion (37). The majority of the newly 
synthesized PrP produced in both normal and scrapie  N2a 
cells during a 2-h pulse period was accessible to sulfo-NHS- 
biotin (Fig.  4,  lanes 3  and 4).  After immunoprecipitation, 
the biotin-tagged samples  were divided and one-half incu- 
bated with streptavidin in the presence of excess d-biotin (lane 
3)  and the other aliquot  incubated  with streptavidin  alone 
(lane 4). Streptavidin binding to biotinylated PrP retarded its 
migration into SDS-PAGE (Fig. 4, lane 4), indicating that the 
majority of newly synthesized PrP accumulates on the sur- 
face of both normal and scrapie N2a cells.  When the fourth 
lanes of Fig. 4, A and B are compared, slightly more newly 
synthesized  PrP produced  in ScN2a cells  was inaccessible 
to  sulfo-NHS-biotin than  in control,  uninfected  N2a cells. 
Whether this  difference is  significant remains to be estab- 
lished.  No difference between the uninfected N2a and ScN2a 
cells could be discerned with respect to the extent of nascent 
PrP release by PIPLC. 
only (lane 4). Lanes 5 and 6 are the same as lanes 3 and 4 without 
the added control biotinylated  protein.  Lane 7 is a proteinase  K-di- 
gested extract of nonbiotinylated  ScN2a culture electrophoresed in 
the presence of 200 #g streptavidin. 
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cells in 25-cm  2 flasks were metabolically radiolabeled for 2 h with 
300 #Ci/ml  [35S]methionine in methionine-frec DME with 2.5% 
dialyzed FBS after a 1-h preincubation in methionine-free medium. 
Cultures were then incubated in serum-frec medium containing un- 
labeled methionine (Opti-MEM I) for increasing periods of time. 
Cell extracts were digested with proteinase K (even-numbered  lanes 
only) followed by immunoprecipitation of DLPCs with immune 
R017 serum. Lanes 1 and 2, no chase incubation. Lanes 3 and 4, 
2-h chase. Lanes 5 and 6, 6-h chase. Lanes 7 an4 8, 24-h chase. 
(B) Degradation of PrP  c in uninfected N2a cells after a 2-h pulse 
of [3SS]methionine. The radioantograph shown above (A) (-zx-) 
and one from a duplicate experiment (-[]-) were densitometri- 
cally scanned and the values plotted as a function of the chase 
period.  Values for PrP  c are expressed as a percent of the signal 
detected at the end of the pulse period; i.e., no chase. 
Synthesis and Degradation of  PrP  c 
Metabolic  pulse-chase  radiolabeling  with  [35S]methionine 
was used to study PrP biosynthesis and degradation in nor- 
mal and scrapie-infected N2a cells. Radiolabeled PrP mole- 
cules were immunoprecipitated after increasing periods of 
chase and  analyzed by SDS-PAGE.  Prominent 33-35-kD 
PrP bands were observed for both uninfected N2a (Fig. 5 A) 
and  ScN2a  cells  (Fig.  6  A)  immediately  following a  2-h 
pulse of radiolabeling (lane/). In uninfected N2a cells, the 
PrP  c signal declined as a function of the chase period (Fig. 
5 A; lanes 3, 5, and 7correspond to 2 h, 6 h and 24 h of  chase, 
respectively). Digestion of N2a cell extracts with proteinase 
K before immunoprecipitation resulted in no detectable ra- 
diolabeled products (Fig. 5 A, lanes 2, 4, 6, and 8 correspond 
to 0 h, 2 h, 6 h, and 24 h of chase, respectively). 
The autoradiograph shown in Fig. 5 A, as well as that from 
a similar experiment, was analyzed by densitometry and the 
peak areas are plotted in Fig. 5 B as the fraction of the signal 
observed in  the absence of a  chase.  The two sets of data 
points show excellent reproducibility and can be fit by a line 
for an exponential decay with a half-time of 5.2 h. We must 
emphasize,  however, that no effort was made to check the 
linearity of  film response in these experiments, and the quan- 
titation should be considered approximate. These results are 
in good agreement with those recently reported by other in- 
vestigators (9). 
Kinetics of  PrP  s~ Synthesis 
Metabolic radiolabeling studies gave a strikingly different re- 
sult when ScN2a cells were analyzed for proteinase K-resis- 
tant PrP molecules. Immediately following the 2-h pulse la- 
beling period, no proteinase K-resistant PrP molecules were 
found (Fig. 6 A, lane 2). With increasing intervals of chase, 
proteinase K-resistant PrP molecules became evident (Fig. 
6 A, lanes 4, 6, 8, 10, 12, and 14 correspond to 2 h, 4 h, 6 h, 
10 h, 24 h, and 48 h of chase, respectively). This indicates 
that PrP  s~ is derived from a proteinase K-sensitive precursor. 
Lanes 15-17are controls showing that the proteinase K-resis- 
tant PrP  s~ molecules are not immunopurified by preimmune 
monospecific antipeptide (P1) sera (3) (Fig. 6, lane 15) while 
immune  serum (Fig.  6,  lane  16)  precipitates radiolabeled 
Prl  ~. The immunoprecipitation of PrP  s~ with this antiserum 
was prevented by preincubation with the P1 synthetic peptide 
(Fig. 6, lane 17), thereby confirming the identity of the puta- 
tive PrP bands. 
The total amount of PrP  c recovered in the nonproteinase 
K  digested fractions of radiolabeled cell extracts declined 
with increasing chase time (Fig. 6 A, odd-numbered lanes). 
This suggests that a significant fraction of the newly synthe- 
sized PrP molecules produced in ScN2a  cells are destined 
for cellular degradation.  Since we cannot distinguish  the 
proteinase K digestable precursor of PrP  s~ from PrP  c, it is 
not possible,  at present,  to determine if the rate of PrP  c 
degradation in  ScN2a  cells differs from that in uninfected 
N2a cells. 
Fig. 6 B shows  a plot of sum of the densitometric values 
obtained for the three protease-resistant PrP bands in Fig. 6 
A as a function of chase time, as well as that obtained from 
a similar experiment. The points are reasonably fit by a line 
describing  an exponential appearance  with a  half-time of 
15.2 h. Although this number should be considered only as 
a rough estimate of the rate constant for Prl  ~  synthesis, it 
is clear that it is much slower than that for PrP  c synthesis 
and significantly slower than the rate constant for PrP  c dis- 
appearance. 
Release of  PrP  c from ScN,  a Cells 
To determine whether PrP  s~ is secreted from ScN2a cells, 
aliquots of the culture medium were analyzed for PrP im- 
munoreaetivity. Figs. 7, A and B, show that similar amounts 
of PrP are released into the culture medium of uninfected 
N2a and ScN2a cells over a  16-h chase incubation (compare 
The Journal of Cell Biology, Volume  110, 1990  748 Figure 6.  Kinetics of PrP  s~ biosynthesis. (A) Confluent T25 flasks of ScN2a cultures were metabolically radiolabeled for 2 h as in Fig. 
5. Cultures were then chase-incubated in Opti-MEM I before detergent extraction, proteinase K digestion, and immunoprecipitation in 
DLPCs as in Fig. 5. Lanes 1 and 2, no chase without (-) and with exposure to proteinase K (+). Lanes 3 and 4, 2-h chase (-) and proteinase 
K (+). Lanes 5 and 6, 4-h chase (-) and proteinase K (+). Lanes 7and 8, 6-h chase (-) and proteinase K (+). Lanes 9 and 10, 10-h chase 
(-) and proteinase K (+).  Lanes//and  12, 24-h chase (-) and (+) proteinase K. Lanes 13 and 14, 48-h chase (-) and proteinase K 
(+).  Lanes 15-17 are controls to demonstrate the specificity of antisera to the proteinase K-resistant PrP-reactive molecules found  in 
ScN2a cells. Lane 15, preimmune antipeptide P1 sera R013 (Gly-Gln-Gly-Gly-Thr-His-Asn-Gln-Trp-Asn-Lys-Pro-Gly-Gly-Cys).  Lane 16, 
immune anti-Pl sera R013. Lane 17, immune anti-P1  sera R013 preincubated with 25 #g P1 peptide.  (B) Accumulation of PrP  sc in ScN2a 
cells after a 2-h pulse of [35Slmethionine.  The radioantograph shown above (-zx-) and one from a similar experiment (-t2-)  were den- 
sitometrically scanned.  The sum of the values for the 3 PrP  s~ species (a, even-numbered lanes) were plotted as a function of the chase 
period. Values  for PrP  sc are expressed as a percent of the 33-35-kD PrP signal detected at the end of the pulse period (a,  lane 1). 
lane 4  in Fig. 7, A and B, normal and ScN2a,  respectively). 
The PrP released from both cells into the media was found 
to be readily  digested  with  proteinase  K  arguing  that only 
PrP  c  is released.  This finding  is consistent  with  studies by 
others (9) reporting that a  portion of PrP  c is released from 
uninfected  and  scrapie-infected  N2a  cells.  The  kinetics  of 
PrP  c appearance in the culture medium from ScN2a cells is 
depicted in Fig.  7  C. A  plot of the densitometric  values for 
the spontaneous  release of PrP  c from ScN2a cells is shown 
in Fig.  7 D. The best fit to a  single exponential  curve gives 
a half-time of 10.5 h. It is intriguing that the time course of 
PrP  c release parallels the synthesis of PrP  s~ as illustrated  in 
Figs.  6  B  and  7  D. 
Discussion 
Although  a  wealth  of  evidence  argues  persuasively  that 
PrP  s~ is a major and necessary component of the infectious 
prion particle,  some investigators continue to challenge this 
premise (1,  11,  30,  36).  In general,  these investigators have 
encountered difficulty in detecting PrP s~ in a specific extract 
or fraction and have concluded  that its apparent absence is 
evidence for a dissociation between PrP  s~ and scrapie infec- 
tivity. In part, these problems are quantitative since the bio- 
assay is extremely sensitive while PrP  s~ detection relies on 
immunodetection  of samples subjected  to limited proteoly- 
sis.  The  propensity  of  PrP  s~  to  form  aggregates  and  the 
difficulties  attendant  with  its  solubilization  create an addi- 
tional  level of complexity. 
Contrasting Properties of PrP  c and PrP  s~ 
The studies  described  here on  PrP  sc biogenesis  and  topol- 
ogy are  the  first to  report detection  of. radiolabeled  PrP  s~. 
These results complement those previously reported for the 
two  PrP  isoforms  (Table I).  Purified  prions  are composed 
largely, if not entirely, of PrP  s~ molecules.  Limited proteol- 
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prp  c  prp  s~ 
Normal cells  +  - 
Scrapie-infected cells  +  + 
Purified prions  -  + 
Protease resistance  -  +  (PrP 27-30) 
Amyloid rods  -  +  (PrP 27-30) 
Subeellular localization  Cell surface  Primarily  intraceilular 
PIPLC release  +  - 
Synthesis  <2 h  ,x,15 h 
Turnover  (tit2)  r'5 h  >24 h 
Figure 7. Release of PrP  c into cell culture medium from N2a and 
ScN2a  cells.  (A)  N2a  and  (B)  SeN2a  cells  were  labeled  with 
[35S]methionine for 2 h followed by a chase period of 2 h (lanes  1 
and 2) or 16 h (lanes 3 and 4).  Cells (lanes  1 and 3) and media 
(lanes 2 and 4) were harvested and analyzed for PrP molecules.  Im- 
munoprecipitations  were performed with R017 antisera.  (C) Time 
course for release of PrP  c into culture medium from SeN2a cells. 
The labeling and chase medium from cultures used in Fig. 6A were 
harvested  and examined.  Lane 1, labeling  medium. Lane 2, 2-h 
chase medium.  Lane 3,  4-h chase medium.  Lane 4,  6-h chase 
medium. Lane 5, 10-h chase medium. Lane 6, 24-h chase medium. 
Lane 7, 48-h chase medium. (D) Radioautograph  above in C was 
analyzed densitometrically  and  the  values  (--A--)  plotted  as  a 
function  of the chase time. 
ysis degrades  PrP  s~ by hydrolyzing only the  NH: terminal 
67 amino acids to produce PrP 27-30 (25, 29). Detergent ex- 
traction of membranes  containing PrP 27-30 results  in the 
polymerization of this protein in rod-shaped particles indis- 
tinguishable from amyloids (23, 28). Although both PrP iso- 
forms possess  glycosyl-phosphatidylinositol anchors,  PrP  c 
is localized primarily on the cell surface while PrP  s~ is found 
mainly within the cell.  PrP  c  is released  from the cell  sur- 
face by PIPLC digestion  but  PrP  s~  is  resistant  to  release. 
PrP  c synthesis and maturation are rapid as evidenced by the 
large amount of radiolabeled PrP  c found after a  2-h pulse. 
Other  investigators  suggest  that  the  t~a  for  PrP  c  synthesis 
may be as small as 20 min (9).  Our studies show that PrP  c 
turns  over with  a  t,/2 of 5.2 h.  In contrast,  PrP  s¢ synthesis 
and  maturation  is  slow  with  a  t~2  of 15.2  h.  We have  not 
been able to demonstrate the degradation of PrP  ~ in cultured 
cells; presumably, this process is extremely slow with a  t,~2 
>24h. 
SubceUular Localization  of  PrP lsoforms 
We  found that  ~50%  of the  PrP  c  molecules  produced  in 
either  uninfected,  or  scrapie-infected  Nea  cells  could  be 
released by PIPLC digestion (see Fig. 4). In both uninfected 
N2a cells  and  ScN2a cells,  most of the  newly synthesized 
PrP  c  molecules  could  be  labeled  with  sulfo-NHS-biotin. 
This suggests that some cell surface PrP  c molecules may be 
resistant to PIPLC digestion.  However,  it appears that it is 
not uncommon for cells to produce subpopulations of GPI 
anchored proteins that cannot be released by PIPLC diges- 
tion (18,  19).  Most PrP  s¢ produced in ScN2a cells  appears 
to be inaccessible to labeling with sulfo-NHS-biotin (see Fig. 
3). This result is consistent with recent immunofluorescence 
studies of ScN2a cells showing that PrP  s~ accumulates with- 
in the interior of cells (Taraboulos, A., D. Serban, and S. B. 
Prusiner,  submitted  for publication). 
Posttranslational  Processing 
Our experiments have demonstrated that a protein indistin- 
guishable from PrP  c is present in ScN2a cells.  Since a high 
proportion of the cells  also contain PrP  s¢ and produce in- 
fectious prions,  synthesis of PrP  c and PrP  s¢ are not mutu- 
ally exclusive.  Whereas PrP  c may be observed in both nor- 
mal and scrapie-infected N2a cells following a brief (1-2 h) 
metabolic labeling period, detection of significant quantities 
of  mature,  protease-resistant  PrP  s~  requires  a  prolonged 
chase period.  Therefore,  PrP  sc is derived from a  protease- 
sensitive  precursor.  Acquisition  of protease  resistance  en- 
sues slowly with an estimated half-time for synthesis of 15 h. 
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tease resistance. We estimate that ,~30% of the PrP chains 
acquire protease resistance based on the data presented in 
Figs.  1 and 6. Our estimates suffer from uncertainties about 
the efficiencies of PrP  c and PrP  s~ transfer to nitrocellulose 
membranes  as  well  as  our  assumption  that  virtually  all 
PrP  c is released by PIPLC digestion. In addition, the rela- 
tive efficiency of immunoprecipitation of radiolabeled PrP 
molecules in DLPCs is unknown. In spite of these uncertain- 
ties,  immunoblot  analysis  and  metabolic labeling  studies 
give similar estimates. 
Both  normal  and  ScN2a  cells  spontaneously  release  a 
protease-sensitive form of PrP. We note that the sum of the 
estimated rate constants for production of the extracellular 
form (0.066h-') and for formation of the protease-resistant 
form (0.046h-')  approximates the  rate constant  for disap- 
pearance of PrP  c in normal cells (0.13h-'). It follows that a 
large proportion of PrP molecules destined for intracellular 
degradation in uninfected cells might serve as substrates for 
conversion to PrP  s~ in infected cells. 
The organization of the PrP gene argues that the cellular 
and scrapie isoforms do not arise from alternative splicing 
since the entire open reading frame is contained within a sin- 
gle exon (4).  Furthermore, there is no evidence for DNA 
rearrangements of the  PrP gene during  scrapie infection. 
Based on these observations,  we suggested that PrP  c  and 
PrP  s~ differ because of some posttranslational event (4). 
We are unable to determine from our present experiments 
whether  the  precursor of PrP  s~  is  identical  to or distinct 
from PrP  c. PrP  s~ might be derived directly from PrP  c via a 
subsequent posttranslational event, perhaps an abrogation of 
a normal cellular process. Alternatively, a distinct protease- 
sensitive  precursor  to  PrP  s~  could  be  synthesized  which 
would be committed toward formation of the protease-resis- 
tant form at an early stage of biosynthesis. In either event, 
it is clear from our present study that the biochemical prop- 
erty of protease-resistance is acquired posttranslationally. 
Slow Accumulation of  PrP ~ and the Scrapie 
Incubation Period 
Although scrapie has been successfully transmitted to cul- 
tured cells on many occasions (8, 20,  30,  31,  33), the low 
prion  titer  observed  (usually  104-105 IDs0/ml  of extract) 
contrasts markedly with those found in the brains of scrapie- 
infected  hamsters  exhibiting  clinical  signs  of scrapie.  In 
brain,  titers  in  excess  of l0  s IDs0/ml  of homogenate and 
correspondingly high  concentrations  of PrP  s~  are  found. 
Our data suggest a simple explanation for this paradox. A 
continuous culture of scrapie-infected cells such as that de- 
scribed here may be  unable  to  accumulate  high  titers  of 
PrP  s~  (and  by  inference,  infectious  particles)  because  of 
constant dilution by ongoing cell division. In contrast, high 
titers in the brain may be achieved because prions replicate 
primarily in nondividing neurons. The extreme stability of 
PrP  s~ compared to PrP  c would allow accumulation to high 
concentrations during the extremely protracted incubation 
period that is characteristic of prion diseases. 
New Approaches Arising from these Studies 
The  identification  of conditions  for  the  radiolabeling  of 
PrP  s" in scrapie-infected cultured cells and its detection af- 
ter SDS-PAGE should open many new approaches to the 
study of prions.  Learning which inhibitors of posttransla- 
tional processing and transport prevent PrP  s~ synthesis may 
elucidate the posttranslational  event responsible for PrP  s~ 
formation. For example, numerous inhibitors have become 
available which block specific steps in the synthesis and pro- 
cessing of Asn-linked complex oligosaccharides. Both PrP  c 
and PrP  s` are known to be modified by complex oligosac- 
charides (7, 12, 15). Elucidating the nature of these chemical 
reactions as well as identifying the rate limiting step will add 
significantly to our understanding of prion diseases.  Thus, 
dynamic studies  involving inhibitors of cellular functions 
and a more detailed exploration of precursor-product rela- 
tionships  in  ScN2a  cells  may  elucidate the  nature  of the 
PrP  s` precursor and its relationship to PrP  c. 
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